β-Catenin-Cohesin Ring-CEGRs/ALCDs Axis Activation Contributes to the Development of Hepatoblastoma and Fibrolamellar HCC
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2025 · 1 min read
In brief
In brief
This study identifies a novel β-catenin-cohesin ring mechanism driving oncogene activation in pediatric hepatoblastoma and adolescent fibrolamellar HCC through chromosomal reorganization at cancer-enhancing genomic regions. Cohesin complex proteins are dramatically overexpressed in patient samples and create DNA loops that amplify oncogene transcription, with cohesin inhibition reducing tumor cell proliferation in vitro.
Written by the GCMD Library team from the article.
Statements in this article
Hepatoblastoma and fibrolamellar hepatocellular carcinoma require aggressive surgery when feasible and nontargeted toxic chemotherapy for a chance of cure.
ph-S675-β-catenin plays an essential role in the reorganization of genomic structure in hepatoblastoma and fibrolamellar hepatocellular carcinoma through oncogenic activation via cancer-enhancing genomic regions or aggressive liver cancer domains.
In fibrolamellar hepatocellular carcinoma, the fusion DNAJB1-PKAc oncoprotein phosphorylates β-catenin at Ser675, triggering CEGRs/ALCDs-mediated activation of oncogenes.
All members of the cohesin ring—CTCF, Rad21, SMC1, SMC3, and STAG1—and β-catenin-TCF4 are bound to CEGRs/ALCDs of oncogenes in hepatoblastoma and fibrolamellar hepatocellular carcinoma.
Cohesin ring binding to CEGRs/ALCDs increases transcription of oncogenes.
Cohesin ring expression is dramatically elevated in the majority of hepatoblastoma and fibrolamellar hepatocellular carcinoma samples.
The cohesin ring and the ph-S675-β-catenin-TCF4-p300 complex are detected on both the promoter and intron-located CEGRs/ALCDs of NRF2 and Thy1, correlating with increased transcription.
The cohesin ring creates the DNA loop for oncogene activation.
Inhibition of the cohesin ring by JQ1 reduces the proliferation of hepatoblastoma and fibrolamellar hepatocellular carcinoma cells in culture.